Sarcopenia: Molecular Mechanism and Treatment Strategies provides answers and guidance on a disease that has serious health consequences in terms of fractures, frailty, disability and diminished quality of life. Written by experts around the world, this book is for all those that care for aging populations. As the global population ages, sarcopenia remains a therapeutic challenge and major public health concern. Difficulties in defining sarcopenia as a clinical phenotype remain and have hindered treatment.
1. Sarcopenia - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Linking mitochondrial dysfunction to sarcopenia - p. Page vii 10. Chapter 2 : The role of the neuromuscular junction in sarcopenia - p. Page 32 11. Chapter 3 : Dietary approaches to maintaining muscle mass - p. Page 75 12. Chapter 4 : Role of muscle stem cells in sarcopenia - p. Page 100 13. Chapter 5 : Sarcopenia and the inflammatory cytokines - p. Page 129 14. Chapter 6 : Molecular mechanisms of exercise providing therapeutic rationale to counter sarcopenia - p. Page 152 15. Chapter 7 : Myokines: A potential key factor in development, treatment, and biomarker of sarcopenia - p. Page 166 16. Chapter 8 : Defect of autophagy signaling in sarcopenic muscle - p. Page 180 17. Chapter 9 : Mitophagy in sarcopenic muscle and practical recommendations for exercise training - p. Page 200 18. Chapter 10 : Underlying mechanisms of sarcopenic obesity - p. Page 221 19. Chapter 11 : Vascular aging and sarcopenia: Interactions with physiological functions during exercise - p. Page 242 20. Chapter 12 : Dysphagia of cachexia and sarcopenia - p. Page 260 21. Chapter 13 : Mechanisms of decline in muscle quality in sarcopenia - p. Page 283 22. Index - p. Page 313
Sarcopenia: Molecular Mechanism and Treatment Strategies provides answers and guidance on a disease that has serious health consequences in terms of fractures, frailty, disability and diminished quality of life. Written by experts around the world, this book is for all those that care for aging populations. As the global population ages, sarcopenia remains a therapeutic challenge and major public health concern. Difficulties in defining sarcopenia as a clinical phenotype remain and have hindered treatment.
1. Sarcopenia - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Linking mitochondrial dysfunction to sarcopenia - p. Page vii 10. Chapter 2 : The role of the neuromuscular junction in sarcopenia - p. Page 32 11. Chapter 3 : Dietary approaches to maintaining muscle mass - p. Page 75 12. Chapter 4 : Role of muscle stem cells in sarcopenia - p. Page 100 13. Chapter 5 : Sarcopenia and the inflammatory cytokines - p. Page 129 14. Chapter 6 : Molecular mechanisms of exercise providing therapeutic rationale to counter sarcopenia - p. Page 152 15. Chapter 7 : Myokines: A potential key factor in development, treatment, and biomarker of sarcopenia - p. Page 166 16. Chapter 8 : Defect of autophagy signaling in sarcopenic muscle - p. Page 180 17. Chapter 9 : Mitophagy in sarcopenic muscle and practical recommendations for exercise training - p. Page 200 18. Chapter 10 : Underlying mechanisms of sarcopenic obesity - p. Page 221 19. Chapter 11 : Vascular aging and sarcopenia: Interactions with physiological functions during exercise - p. Page 242 20. Chapter 12 : Dysphagia of cachexia and sarcopenia - p. Page 260 21. Chapter 13 : Mechanisms of decline in muscle quality in sarcopenia - p. Page 283 22. Index - p. Page 313
